234 related articles for article (PubMed ID: 30531861)
1. Cyclin A2/E1 activation defines a hepatocellular carcinoma subclass with a rearrangement signature of replication stress.
Bayard Q; Meunier L; Peneau C; Renault V; Shinde J; Nault JC; Mami I; Couchy G; Amaddeo G; Tubacher E; Bacq D; Meyer V; La Bella T; Debaillon-Vesque A; Bioulac-Sage P; Seror O; Blanc JF; Calderaro J; Deleuze JF; Imbeaud S; Zucman-Rossi J; Letouzé E
Nat Commun; 2018 Dec; 9(1):5235. PubMed ID: 30531861
[TBL] [Abstract][Full Text] [Related]
2. Recurrent AAV2-related insertional mutagenesis in human hepatocellular carcinomas.
Nault JC; Datta S; Imbeaud S; Franconi A; Mallet M; Couchy G; Letouzé E; Pilati C; Verret B; Blanc JF; Balabaud C; Calderaro J; Laurent A; Letexier M; Bioulac-Sage P; Calvo F; Zucman-Rossi J
Nat Genet; 2015 Oct; 47(10):1187-93. PubMed ID: 26301494
[TBL] [Abstract][Full Text] [Related]
3. Ccne1 Overexpression Causes Chromosome Instability in Liver Cells and Liver Tumor Development in Mice.
Aziz K; Limzerwala JF; Sturmlechner I; Hurley E; Zhang C; Jeganathan KB; Nelson G; Bronk S; Fierro Velasco RO; van Deursen EJ; O'Brien DR; Kocher JA; Youssef SA; van Ree JH; de Bruin A; van den Bos H; Spierings DCJ; Foijer F; van de Sluis B; Roberts LR; Gores GJ; Li H; van Deursen JM
Gastroenterology; 2019 Jul; 157(1):210-226.e12. PubMed ID: 30878468
[TBL] [Abstract][Full Text] [Related]
4. Cyclin E1 and cyclin-dependent kinase 2 are critical for initiation, but not for progression of hepatocellular carcinoma.
Sonntag R; Giebeler N; Nevzorova YA; Bangen JM; Fahrenkamp D; Lambertz D; Haas U; Hu W; Gassler N; Cubero FJ; Müller-Newen G; Abdallah AT; Weiskirchen R; Ticconi F; Costa IG; Barbacid M; Trautwein C; Liedtke C
Proc Natl Acad Sci U S A; 2018 Sep; 115(37):9282-9287. PubMed ID: 30150405
[TBL] [Abstract][Full Text] [Related]
5. Effects of E2F1-cyclin E1-E2 circuit down regulation in hepatocellular carcinoma cells.
Farra R; Dapas B; Pozzato G; Scaggiante B; Agostini F; Zennaro C; Grassi M; Rosso N; Giansante C; Fiotti N; Grassi G
Dig Liver Dis; 2011 Dec; 43(12):1006-14. PubMed ID: 21831731
[TBL] [Abstract][Full Text] [Related]
6. Induction of cell cycle arrest via the p21, p27-cyclin E,A/Cdk2 pathway in SMMC-7721 hepatoma cells by clioquinol.
Huang Z; Wang L; Chen L; Zhang Y; Shi P
Acta Pharm; 2015 Dec; 65(4):463-71. PubMed ID: 26677902
[TBL] [Abstract][Full Text] [Related]
7. Regulation of cell cycle of hepatocellular carcinoma by NF90 through modulation of cyclin E1 mRNA stability.
Jiang W; Huang H; Ding L; Zhu P; Saiyin H; Ji G; Zuo J; Han D; Pan Y; Ding D; Ma X; Zhang Y; Wu J; Yi Q; Liu JO; Huang H; Dang Y; Yu L
Oncogene; 2015 Aug; 34(34):4460-70. PubMed ID: 25399696
[TBL] [Abstract][Full Text] [Related]
8. Chromatin remodeling gene ARID2 targets cyclin D1 and cyclin E1 to suppress hepatoma cell progression.
Duan Y; Tian L; Gao Q; Liang L; Zhang W; Yang Y; Zheng Y; Pan E; Li S; Tang N
Oncotarget; 2016 Jul; 7(29):45863-45875. PubMed ID: 27351279
[TBL] [Abstract][Full Text] [Related]
9. Kinase-independent function of E-type cyclins in liver cancer.
Geng Y; Michowski W; Chick JM; Wang YE; Jecrois ME; Sweeney KE; Liu L; Han RC; Ke N; Zagozdzon A; Sicinska E; Bronson RT; Gygi SP; Sicinski P
Proc Natl Acad Sci U S A; 2018 Jan; 115(5):1015-1020. PubMed ID: 29339491
[TBL] [Abstract][Full Text] [Related]
10. Novel pre-mRNA splicing of intronically integrated HBV generates oncogenic chimera in hepatocellular carcinoma.
Chiu YT; Wong JK; Choi SW; Sze KM; Ho DW; Chan LK; Lee JM; Man K; Cherny S; Yang WL; Wong CM; Sham PC; Ng IO
J Hepatol; 2016 Jun; 64(6):1256-64. PubMed ID: 26867494
[TBL] [Abstract][Full Text] [Related]
11. Waltonitone inhibits proliferation of hepatoma cells and tumorigenesis via FXR-miR-22-CCNA2 signaling pathway.
Yang F; Gong J; Wang G; Chen P; Yang L; Wang Z
Oncotarget; 2016 Nov; 7(46):75165-75175. PubMed ID: 27738335
[TBL] [Abstract][Full Text] [Related]
12. Expression of cyclin D1, cyclin E, cdk4 and loss of heterozygosity of 8p, 13q, 17p in hepatocellular carcinoma: comparison study of childhood and adult hepatocellular carcinoma.
Kim H; Lee MJ; Kim MR; Chung IP; Kim YM; Lee JY; Jang JJ
Liver; 2000 Apr; 20(2):173-8. PubMed ID: 10847487
[TBL] [Abstract][Full Text] [Related]
13. Targeting ODC1 inhibits tumor growth through reduction of lipid metabolism in human hepatocellular carcinoma.
Choi Y; Oh ST; Won MA; Choi KM; Ko MJ; Seo D; Jeon TW; Baik IH; Ye SK; Park KU; Park IC; Jang BC; Seo JY; Lee YH
Biochem Biophys Res Commun; 2016 Sep; 478(4):1674-81. PubMed ID: 27592554
[TBL] [Abstract][Full Text] [Related]
14. Expression of a cyclin E1 isoform in mice is correlated with the quiescent cell cycle status of hepatocytes in vivo.
Zschemisch NH; Liedtke C; Dierssen U; Nevzorova YA; Wüstefeld T; Borlak J; Manns MP; Trautwein C
Hepatology; 2006 Jul; 44(1):164-73. PubMed ID: 16799991
[TBL] [Abstract][Full Text] [Related]
15. Argininosuccinate lyase interacts with cyclin A2 in cytoplasm and modulates growth of liver tumor cells.
Hung YH; Huang HL; Chen WC; Yen MC; Cho CY; Weng TY; Wang CY; Chen YL; Chen LT; Lai MD
Oncol Rep; 2017 Feb; 37(2):969-978. PubMed ID: 28035420
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of BIRC6 Is a Predictor of Prognosis for Colorectal Cancer.
Hu T; Weng S; Tang W; Xue R; Chen S; Cai G; Cai Y; Shen X; Zhang S; Dong L
PLoS One; 2015; 10(5):e0125281. PubMed ID: 25933218
[TBL] [Abstract][Full Text] [Related]
17. miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
Yen CS; Su ZR; Lee YP; Liu IT; Yen CJ
World J Gastroenterol; 2016 Jun; 22(22):5183-92. PubMed ID: 27298561
[TBL] [Abstract][Full Text] [Related]
18. Association of downregulation of cyclin D1 and of overexpression of cyclin E with p53 mutation, high tumor grade and poor prognosis in hepatocellular carcinoma.
Peng SY; Chou SP; Hsu HC
J Hepatol; 1998 Aug; 29(2):281-9. PubMed ID: 9722210
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive analyses of mutations and hepatitis B virus integration in hepatocellular carcinoma with clinicopathological features.
Kawai-Kitahata F; Asahina Y; Tanaka S; Kakinuma S; Murakawa M; Nitta S; Watanabe T; Otani S; Taniguchi M; Goto F; Nagata H; Kaneko S; Tasaka-Fujita M; Nishimura-Sakurai Y; Azuma S; Itsui Y; Nakagawa M; Tanabe M; Takano S; Fukasawa M; Sakamoto M; Maekawa S; Enomoto N; Watanabe M
J Gastroenterol; 2016 May; 51(5):473-86. PubMed ID: 26553052
[TBL] [Abstract][Full Text] [Related]
20. Upregulated FoxM1 expression induced by hepatitis B virus X protein promotes tumor metastasis and indicates poor prognosis in hepatitis B virus-related hepatocellular carcinoma.
Xia L; Huang W; Tian D; Zhu H; Zhang Y; Hu H; Fan D; Nie Y; Wu K
J Hepatol; 2012 Sep; 57(3):600-12. PubMed ID: 22613004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
